SCIBASE HOLDING AB revenue for the last year amounted to 23.25 M SEK, the most of which — 16.31 M SEK — came from its highest performing source at the moment, Skin Cancer, the year earlier bringing 10.69 M SEK. The greatest contribution to the revenue figure was made by Germany — last year it brought SCIBASE HOLDING AB 13.83 M SEK, and the year before that — 8.66 M SEK.